Insider Purchases: Inside the Buy
Tag: Funanc1al Investing
🏛️ S&P Global (SPGI): The Toll Booth of Capitalism Gets a “Sale” Sign
S&P Global isn’t just a company—it’s the infrastructure of modern finance. With valuation down ~30% and insiders buying, is this a rare opportunity to own a wide-moat compounder at a discount?
🩺 GE HealthCare (GEHC): Insider Buying, AI Growth & a $21B Backlog Opportunity
GE HealthCare (GEHC) is quietly shaping up as a high-visibility MedTech play, combining insider buying, a $21.8B backlog, and AI-driven diagnostics. With valuation still reasonable and institutional ownership near record levels, this could be a compelling long-term compounder—if you’re patient on entry.
🍫 Simply Good Foods (SMPL): Low Carb, Low Price, or Just Low Expectations?
Simply Good Foods (SMPL) is down sharply, trading at bargain-style valuation levels while insiders keep buying. Is this protein-packed stock a turnaround snack—or a melting low-carb ice cube?
Badger Meter (BMI) Stock Analysis 2026: Insider Buys After 24% Crash 💧📉
Badger Meter just took a 24% hit—but the CEO is buying the dip. With strong long-term water infrastructure trends and improved valuation, is BMI a hidden opportunity or just treading water?
Conagra (CAG): 9% Yield Bargain or Value Trap? 🥫📉
Conagra (CAG) is down big, insiders are buying, and the dividend is near 9%. Is this a deep-value opportunity—or a trap in disguise? 🥫
📈 Top 10 Insider Buys April 2026: CEOs Buying OSCR, NKE, LW & More
CEOs, directors, and 10% owners are writing real checks again. From Oscar Health’s massive $11.9M buy to Nike’s continued dip-buying, here are the most interesting insider moves of April 2026.
CEO Bets $11.9M: Is Oscar Health (OSCR) About to Shock the Market? 🚀
Oscar Health (OSCR) is no longer just a flashy disruptor—it’s aiming for profitability. With CEO Mark Bertolini buying $11.9M in stock and revenue projected to hit $19B in 2026, this could be one of the most compelling turnaround plays in healthcare.
🛢️ HMH Stock: Insiders Buy Millions After IPO Dip — Opportunity or Trap? 📉📈
HMH just IPO’d… and insiders are already buying millions. From strong margins to a pivot into mining and geothermal, here’s why this overlooked energy stock is getting attention.
Top 10 Insider Buys April 2026: Where CEOs Are Investing Millions Now 📈
When CEOs, directors, and 10% owners buy millions of dollars of their own stock, it’s worth paying attention. Here are the top insider buys of April 2026—and why MGM, PANW, AHCO, and others stand out.
Phreesia (PHR): Profitable… Then Crushed — Why Insiders Are Loading Up
Phreesia just hit profitability—and got punished for it. With insiders loading up and institutions fully committed, is this a classic overreaction or a value trap? Let’s decode the dip.